[ Price : $8.95]
FDA grants Ideaya Biosciences a breakthrough therapy designation for darovasertib for neoadjuvant use in adult patients with prima...[ Price : $8.95]
FDA issues a complete response letter to Aldeyras NDA for reproxalap to treat dry eye disease, citing a lack of efficacy in the su...[ Price : $8.95]
FDA Webview Contributing Editor John Hope says the dismissal of agency communications staff will hurt information flow to the publ...[ Price : $8.95]
Former FDA commissioner Scott Gottlieb predicts just-confirmed FDA commissioner Marty Makary will soon face political interference...[ Price : $8.95]
BeiGene scraps the development of BGB-A1217 (ociperlimab), an anti-TIGIT antibody, as a potential treatment for lung cancer.[ Price : $8.95]
FDAs accelerated approval program faces renewed scrutiny after a recent JAMA study highlighted concerns about cancer drugs that re...[ Price : $8.95]
Biogen wins a fast-track designation for BIIB080, an investigational antisense oligonucleotide therapy for treating Alzheimers dis...[ Price : $8.95]
Former FDA commissioner Mark McClellan says it will be a challenge for the agency to come through the massive reorganization and s...